[Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
Zhonghua Gan Zang Bing Za Zhi
; 26(3): 175-178, 2018 Mar 20.
Article
en Zh
| MEDLINE
| ID: mdl-29804389
ABSTRACT
Hepatitis C is one of the major causes of liver disease worldwide. Chronic hepatitis C can cause liver fibrosis and cirrhosis leading to end-stage liver disease. Antiviral therapy can clear the virus, stop the progress of the disease, thereby reducing the incidence of advanced liver disease. This article aims to discuss the effects and safety of antiviral treatments, including direct- acting antiviral agents, on patients with chronic hepatitis C with fibrosis and compensated and decompensated liver cirrhosis.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
Hepacivirus
/
Hepatitis C Crónica
Límite:
Humans
Idioma:
Zh
Revista:
Zhonghua Gan Zang Bing Za Zhi
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2018
Tipo del documento:
Article
País de afiliación:
China